Healthtech Startups

Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals. The company develops protective antibody therapeutics for hard-to-treat diseases, with an initial focus on neurodegenerative conditions and oncology.

5 investors

Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.

5 investors

Alife Health develops artificial intelligence technology to modernize and personalize the in vitro fertilization (IVF) process for fertility clinics and patients.

5 investors

Aligned operates a marketplace connecting employers with independent advanced and direct primary care physicians, giving working families access to primary care benefits across multiple locations. The company aims to reduce employer healthcare costs and improve health outcomes in the United States.

5 investors

AliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.

5 investors

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

5 investors

Alli Connect provides customized mental health technology solutions designed for first responders to reduce stigma and enhance psychological resilience. The company offers programs, AI-driven therapist matching, and peer connection tools specifically for law enforcement and public safety personnel.

5 investors

Alloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.

5 investors

AllStripes was a health technology company that built a research platform for rare diseases, collecting and de-identifying patients' medical records to power rare disease research. Acquired by PicnicHealth in 2022.

5 investors

Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease. The company focuses on pharmaceutical development and clinical research in the cardiovascular health sector.

5 investors

Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.

5 investors

Amicus is a rare disease biotechnology company developing medicines for people with genetically defined conditions. It operates as a wholly owned subsidiary of BioMarin Pharmaceutical Inc.

5 investors

Terra is a smart sleep system that detects and prevents menopausal hot flashes: a wearable bracelet monitors skin moisture and movement to predict a hot flash and triggers chilled water to flow through a mattress pad for instant cooling. It targets women experiencing menopause-related sleep disruption in the women's health and consumer sleep-technology category.

5 investors

Amplified Sciences is a clinical-stage diagnostics company that has developed an ultra-sensitive optical reporter platform for multi-omics diagnostic tests, aimed at helping clinicians detect, treat, and monitor difficult diseases. Its diagnostics support earlier and more accurate detection, including tests for patients at higher risk of pancreatic cancer.

5 investors

AmplifyMD offers a virtual care platform with EHR integrations, automation, embedded AI tools, and a network of remote specialists that lets hospitals and health systems expand physician capacity and add specialty services. Founded in 2019, it serves hospitals and health systems aiming to deliver timely specialty care across multiple sites.

5 investors

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders. It targets diseases with significant unmet medical needs.

5 investors

AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development. The company was founded on breakthrough research from Karolinska Institutet targeting improved heart muscle contractility through a differentiated mechanism.

5 investors

Andy is an AI-powered ambient scribing platform for home health agencies that automates clinical documentation, compliance checks, and medical coding. The system captures patient visits through voice, generates charts in real time, and integrates with existing electronic medical records systems.

5 investors

Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production. The company's biologically-derived solutions target specific intestinal pathogens without disrupting the healthy microbiome.

5 investors

Anja Health provides cord blood banking and stem cell storage services from umbilical cords and placentas for families. The company aims to make stem cell preservation accessible and affordable for new parents.

5 investors

Annette is a subscription weight-loss coaching program that combines nutritional, behavioral, and physical-activity support with an app, dietitians available by chat, and referral to independent physicians who can evaluate eligibility for GLP-1 obesity treatments. It serves individuals seeking sustainable weight loss with or without medical treatment, primarily in France.

5 investors

Ansel Health provides health benefit solutions focused on cost-sharing and coverage for unexpected medical bills for employer groups and individuals. The company specializes in dental, vision, life, disability, and supplemental health coverage.

5 investors

Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program. Its treatments aim to suppress HBV replication and work toward a functional cure for HBV-infected patients.

5 investors

AOI Biosciences is a Japanese biotech company focused on infectious diseases and autoimmune disorders, combining data analysis technology with proprietary bio-technology. It operates diagnostic testing, drug discovery, and drug discovery support businesses.

5 investors